Main Menu

Advances in Personalized and Precision Medicine, with Dr. Jeffrey Meyerhardt, M.D., MPH

Podcast logoDr. Jeffrey Meyerhardt is the Clinical Director of the Gastrointestinal Cancer Center and Senior Physician at Dana-Farber Cancer Institute. In his research, Dr. Meyerhardt, who also is an Associate Professor of Medicine at Harvard Medical School and co-leader of the Center for Colon and Rectal Cancer at Dana-Farber/Brigham and Women’s Cancer Center, focuses primarily on the influence of diet and lifestyle on outcomes among patients with colorectal cancer (CRC). Dr. Meyerhardt is principal investigator of a national clinical trial testing celecoxib as adjunctive therapy to standard treatment for stage III CRC, and recently became co-chair of the GI Committee for the NCI cooperative group Alliance. He earned his MD from Yale School of Medicine, then completed a residency in internal medicine at Beth Israel Deaconess Medical Center and a medical oncology fellowship at Dana-Farber. He joined the Gastrointestinal Cancer Center at Dana-Farber in 2002 and the faculty at Harvard Medical School in 2002.

Please like & share:

, , , , ,

%d bloggers like this: